Corporate Ethics and Governance  
  Home Guidance Documents Company search File a Report  


Company: GlaxoSmithKline

Track this Company

New York sues GlaxoSmithKline

Date Class
19th May 2004 Other Issue
 
Details
The city of New York has sued drug maker GlaxoSmithKline, claiming that the company engaged in "anticompetitive, fraudulent, and inequitable conduct," when it acquired patents for its anti-depressant Paxil.

The suit, filed in federal court in Philadelphia, accuses the company of unfairly keeping generic versions of the drug off the market by obtaining more than a dozen "frivolous" patents on Paxil over the past decade.

The complaint accused the company of violating antitrust laws and seeks repayment of the millions of dollars the city has spent purchasing Paxil for New York residents through the Medicaid program.

 

 

 


Corporate Ethics and Governance is a service from International Charter
Use of this Service is acceptance of the Terms of Agreement
EU Privacy Shield